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Abstract
The cardiac transcription factor Tbx20 has a critical role in the proper morphogenetic development
of the vertebrate heart, and its misregulation has been implicated in human congenital heart
disease. Although it is established that Tbx20 exerts its function in the embryonic heart through
positive and negative regulation of distinct gene programs, it is unclear how Tbx20 mediates
proper transcriptional regulation of its target genes. Here, using a combinatorial proteomic and
bioinformatic approach, we present the first characterization of Tbx20 transcriptional protein
complexes. We have systematically investigated Tbx20 protein-protein interactions by
immunoaffinity purification of tagged Tbx20 followed by proteomic analysis using GeLC-
MS/MS, gene ontology classification, and functional network analysis. We demonstrate that
Tbx20 is associated with a chromatin remodeling network composed of TLE/Groucho co-
repressors, members of the Nucleosome Remodeling and Deacetylase (NuRD) complex, the
chromatin remodeling ATPases RUVBL1/RUVBL2, and the T-box repressor Tbx18. We
determined that the interaction with TLE co-repressors is mediated via an eh1 binding motif in
Tbx20. Moreover, we demonstrated that ablation of this motif results in a failure to properly
assemble the repression network and disrupts Tbx20 function in vivo. Importantly, we validated
Tbx20-TLE interactions in the mouse embryonic heart, and identified developmental genes
regulated by Tbx20:TLE binding, thereby confirming a primary role for a Tbx20-TLE repressor
complex in embryonic heart development. Together, these studies suggest a model in which
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Tbx20 associates with a Gro/TLE-NuRD repressor complex to prevent inappropriate gene
activation within the forming heart.
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Introduction
The development and maturation of a functional heart is a complex process that involves
distinct but overlapping phases of specification, proliferation, migration, differentiation, and
morphogenesis. Disturbances in any of these processes can lead to a number of congenital
heart defects. Currently, congenital heart defects affect nearly 1% of all newborns and are a
significant cause of infant death 1. Recent studies have demonstrated that human patients
with dilated cardiomyopathy, atrial septal defects, or mitral valve disease carry mutations in
the transcription factor Tbx20, while upregulation of Tbx20 gene expression has been
reported in patients with tetralogy of Fallot 2. Tbx20 is a member of the T-box family of
transcription factors, all of which share a well-conserved DNA binding domain known as
the T-box and have diverse roles in embryonic development. Tbx20 has been identified in
many organisms, including Drosophila, zebrafish, Xenopus, and mouse, and in all species
examined Tbx20 transcripts are strongly expressed throughout the developing heart 3.
Results from genetic analysis and protein depletion studies are consistent with a role for
Tbx20 during the early stages of vertebrate heart development; hearts lacking Tbx20 show a
progressive loss of cardiomyocytes, a failure of the heart to undergo looping and chamber
formation, and defects in cardiomyocyte maturation 4. Collectively, these studies suggest
that the sequence, expression, and function of Tbx20 are evolutionarily conserved from flies
to human.
Similar to other T-box factors, Tbx20 is localized to the nucleus, binds DNA in a sequence-
specific manner, and modulates transcription of downstream target genes 4a-e, 5. Results
from a number of studies have shown that Tbx20 can act to both promote and repress target
gene expression in the heart; however, it is unclear how Tbx20 initiates a transcriptional
repressive program within the same cells in which it also acts as a potent transcriptional
activator. It has been proposed that protein co-factors may act to specify Tbx20
transcriptional activity 5c. A model in which protein co-factors act as determinants of Tbx20
activity has several unresolved issues because few in vivo Tbx20 co-factors have been
identified. Additionally, there is uncertainty about the precise mechanism by which binding
of Tbx20 to DNA results in either activation or repression of a target gene. In vitro assays
have been used to demonstrate interactions between Tbx20 and a suite of cardiac
transcription factors that include Tbx5, Nkx2.5, Gata4, Gata5, and Islet1 4a, 5a, although
none of these interactions have been shown to occur in vivo in the embryonic heart. Indeed,
the presence of DNA-binding motifs for Nkx2.5, Gata4, and Tbx5 in the promoter regions of
Tbx20 target genes, in combination with evidence that these transcription factors act
combinatorially to promote target gene expression suggest that cardiac transcription factors
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are important co-factors for Tbx20 to activate gene expression in the developing
heart 4e, 5a, 5c. However, it is not well understood how Tbx20 functions as a transcriptional
repressor as co-factors that may act as functional co-repressors have not been identified.
Therefore, the precise mechanisms by which Tbx20 regulates distinct gene programs in the
heart remains unclear.
To begin to address these questions, we have undertaken, to our knowledge, the first
proteomic study aimed at identifying Tbx20 protein interactions. Using affinity purification
mass spectrometry (AP-MS) 6, we have systematically characterized Tbx20-containing
transcriptional complexes. With this approach, we have identified a unique Tbx20 chromatin
remodeling network that includes the Groucho-related proteins Transducin-like Enhancer of
Split 1 and 3 (TLE1/3), Metastasis-associated Protein 1 (MTA1), the histone-binding
proteins RBBP4 and RBBP7, RUVB-like 1 and 2, Nucleolin, Nucleophosmin, Histone
Deacetylase 2 (HDAC2), and the T-box repressor Tbx18. We provide evidence that Tbx20
recruits TLE1/3 through an evolutionarily conserved N-terminal engrailed homology 1 (eh1)
binding motif, and demonstrate that recruitment of NuRD complex components requires
binding of TLE3 to Tbx20. We find that TLE family members are expressed in mouse
embryonic heart tissue, and that Tbx20 interacts with both TLE1 and TLE3 in vivo during
heart development, representing the first endogenous Tbx20 interactions identified in
embryonic heart tissue to date. Finally, we observe that the Tbx20-TLE interaction is
essential for Tbx20 transcriptional activity in the embryo, and we define a unique set of
genes that are repressed by the Tbx20-TLE transcriptional complex. We propose a model in
which Tbx20 binds to TLE factors to assemble a chromatin remodeling and deacetylase
complex on target gene loci to repress distinct genetic programs in the forming heart.
Materials and Methods
DNA constructs
Mouse Tbx20a cDNA was fused to EGFP and cloned into the pMONO-neo-mcs plasmid
(Invitrogen) for expression in HEK293 cells. The Tbx20eh1mut-EGFP construct was
generated by site-direct mutagenesis (Stratagene) of phenylalanine 18 (F18L) and serine 19
(S19I) using the primers 5’-
CTCTCGAGCCAATGCCTTAATCATCGCCGCGCTTATGTC -3’ and 5’-
GACATAAGCGCGGCGATGATTAAGGCATTGGCTCGAGAG -3’ according to
manufacturer's instructions. To generate the Tbx20-HA construct, mouse Tbx20a cDNA was
fused to an HA epitope and cloned into pMONO-neo-mcs. The pCMV2-TLE1-Flag construct
was generously provided by Dr. Stefano Stifani 7. The pCMX-TLE3 plasmid was kindly
provided by Dr. Peter Tontonoz 8. Tbx18-Flag was generously provided by Dr. Chen-Leng
Cai 9.
Xenopus injections and animal cap isolation
Xenopus laevis embryos were staged according to Nieuwkoop and Faber 10 and injected
with 1 ng Tbx20 or Tbx20-EGFP mRNA at the one-cell stage using established protocols 11.
Animal caps were excised at stage 8-9 and cultured in 1X modified Barth's saline (MBS)
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until sibling embryos reached stage 13. Activin-treated caps were cultured in 8 Units/mL
Activin in 1X MBS.
Isolation of Tbx20-EGFP protein complexes
pMONO-Tbx20-EGFP or Tbx20eh1mut-EGFP plasmids were transfected into HEK293 cells
using FuGENE (Roche Applied Science). Tbx20-EGFP complexes and GFP complexes
were immunoaffinity purified from cells using in-house developed rabbit polyclonal anti-
GFP antibodies conjugated to magnetic beads, as previously described 12. Briefly, HEK293
cells expressing Tbx20-EGFP or GFP alone were washed with cold PBS, harvested from the
plate by scraping with a plastic spatula and pelleted at 1500 rpm for 10 min at 4°C. The cell
pellet was resuspended in 100 μL/1 μg 20 mM HEPES, pH 7.4, containing 1.2%
polyvinylpyrrolidone and protease inhibitors and snap frozen in liquid nitrogen. Cells were
lysed by cryogenic grinding using a Retsch MM 301 Mixer Mill (10 cycles × 2.5 min at 30
Hz) (Retsch, Newtown, PA) and the frozen cell powder was resuspended in optimized lysis
buffer (5 mL/1 g cells) (20 mM K-HEPES pH 7.4, 0.1 M KOAc, 2 mM MgCl2, 0.1%
Tween-20, 1 μM ZnCl2, 1 μM CaCl2, 150 mM NaCl, 0.5% Triton X-100 containing
protease and phosphatase inhibitors). Cell lysates were homogenized using a Polytron
(Kinematica) step (2 × 15 sec) and pelleted at 8000 rpm at 4°C. Cleared lysates were rotated
with 7 mg magnetic beads (M270 Epoxy Dynabeads, Invitrogen) coupled to anti-GFP
antibodies for 1 hr at 4°C. The magnetic beads were then washed in lysis buffer (6 × 1 mL)
(without protease and phosphatase inhibitors) and eluted from the beads in 40 μL 1× LDS
Sample Buffer (Invitrogen) at 70°C for 15 min. Eluted proteins were alkylated with 100 mM
iodoacetamide for 1 hr at room temperature and subjected to mass spectrometry analysis.
Mass spectrometry analysis of Tbx20-EGFP protein complexes
Immunoisolates were analyzed by mass spectrometry as previously described 13 with minor
differences. Briefly, reduced and alkylated eluates were partially resolved by SDS-PAGE on
4-12% Bis-Tris NuPAGE gels (Invitrogen) and stained using SimplyBlue Coomassie stain
(Invitrogen). Each lane was divided into 1 mm slices and binned into 8 wells of a 96-well
plate. Gel slices were destained in 50 mM ammonium bicarbonate (ABC) containing 50%
acetonitrile (ACN). Proteins were digested in-gel with 20 μL of 12.5 ng/μL trypsin in 50
mM ABC for 5 hrs at 37°C. Tryptic peptides were extracted in 0.5% formic acid for 4 hrs at
room temperature, followed by 0.5% formic acid/50% ACN for 2 hrs at room temperature.
The extracted peptides were concentrated by vacuum centrifugation to 10 μL and either
desalted online (trap column, Magic C18 AQ, 100 μm × 2.5cm) or offline using StageTips.
Desalted peptides (4 μL) were separated online by reverse phase C18 (Acclaim PepMap
RSLC, 1.8 μm, 75 μm × 25 cm) over 90 min at 250 nL/min using a Dionex Ultimate 300
nanoRSLC and detected by an LTQ Orbitrap Velos or XL mass spectrometer (Thermofisher
Scientific, San Jose, CA).
The mass spectrometer was operated in data-dependent acquisition mode with dynamic
exclusion enabled. A single acquisition cycle comprised a single full-scan mass spectrum
(m/z = 350–1700) in the Orbitrap (r = 30,000 at m/z = 400), followed by collision-induced
dissociation (CID) fragmentation in the linear ion trap of the top 10 (XL) or 20 (Velos) most
intense precursor ions. FT full scan target value was 1E6 with a max. injection time of 300
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ms. IT tandem MS target values were 5E3 (XL) or 1E4 (Velos) with a maximum injection
time of 100 ms. CID fragmentation was performed at an isolation width of 2.0 Th,
normalized collision energy of 30, and activation time of 30 (XL) or 10 ms (Velos).
Data processing and functional protein analyses
MS/MS spectra were extracted from Thermo RAW files and searched by Proteome
Discoverer/SEQUEST (version 1.3, Thermo Fisher Scientific) against the UniProt SwissProt
protein sequence database (release 2010-11) containing forward and reverse entries from
human and the mouse Tbx20a sequence plus common contaminants (20,324 forward
sequences). SEQUEST search parameters were as follows: full enzyme specificity with 2
missed cleavages, precursor and fragment tolerances, 10 ppm and 0.5 Da, fixed
modification, carbamidomethylation of cysteine, and variable modifications, oxidized
methionine and phosphorylation of STY. SEQUEST peptide spectrum matches (MSF files)
were loaded into Scaffold software (ver. 3.5.1, Proteome Software, Inc), subjected to an X!
Tandem refinement search, and then analyzed by PeptideProphet and ProteinProphet
algorithms to determine peptide and protein probabilities. The high mass accuracy option for
probability scoring was enabled. The following peptide modifications were included in the
X!Tandem refinement search: deamidation of NQ, and acetylation of K and amino-terminus.
Protein groups were assembled by Scaffold and filtered by a minimum of 2 unique peptides.
Probability thresholds were empirically defined to achieve < 1% peptide and protein FDR as
assessed by matches to the reverse database. Proteins descriptions, accession numbers, and
their respective unique peptides and unweighted spectrum counts were exported to Excel for
further analysis.
Specific Tbx20 protein interactions were identified by spectral counting enrichment
analysis 13 comparing the Tbx20-EGFP versus EGFP alone conditions. The following
criteria were applied to each individual replicate (N=3): 1) only proteins with ≥ 5 spectrum
counts were retained, 2) only those proteins that had a spectral count enrichment of ≥ 2.5-
fold versus GFP alone were retained, and 3) using GO annotations, proteins assigned a
“nuclear” localization ontology term were retained (Supplemental Table 1; see
Supplemental Table 2 for proteins excluded for not being associated with a nuclear
localization ontology term). The proteins that fulfilled these criteria in all three replicates
were imported into Cytoscape 14 for classification into functional subgroups according to
biological processes using the plugin ClueGO (Supplemental Table 3) 15. Proteins within
GO term clusters were analyzed in STRING using protein accessions as input 16.
Comparison of interaction protein abundance versus estimated average proteome abundance,
defined here as an enrichment index, was used to identify prominent interaction candidates
from the GO-classified nuclear proteins, as described in 13. To calculate this enrichment
index, first, a protein's spectral counts was normalized within each biological replicate (N =
3) by the Tbx20 spectral count ratio of each individual replicate / average. Then, normalized
spectral counts were converted to NSAF (Normalized Spectral Abundance Factor) values 17
and further normalized by estimated proteome abundance from the human subset of the
PAX (protein abundance across organisms) database 18 (Supplemental Table 4). Tbx20
spectral counts were excluded from this analysis. We have previously shown that calculating
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this enrichment index aids in identifying high confidence interactions that prominently
associate with the bait 13.
Analysis of Tbx20-EGFP and Tbx20eh1mut-EGFP protein complexes using mass
spectrometry-based label-free analysis
Tbx20-EGFP and Tbx20eh1mut-EGFP complexes were immunoisolated and analyzed by LC-
MS/MS as described above. Peptide and protein identifications were filtered using the
criteria described above, including the requirement of at least 5 spectra per protein identified
for either wild-type or mutant isolations and the requirement that all proteins identified in
the wild-type isolation be at least 2.5-fold enriched over isolations from EGFP-expressing
cells. To determine differences in interacting proteins between wild-type and mutant Tbx20
isolations, a combination of spectral counting and MS1 label-free approaches were
employed. For spectral counting analysis, the spectral counts for putative protein
interactions in the Tbx20eh1mut isolation were normalized by the Tbx20 spectral count ratio
of eh1mut/wild-type isolation. Then, the fold-difference in spectral counts of putative
interactions (Tbx20eh1mut isolation relative to wild-type Tbx20) was used to identify
differential interacting proteins. For selected Tbx20 interactions, label-free quantification
was performed by MS1 peak area measurements using the MaxQuant software (ver
1.4.0.8) 19. Relative quantification was performed using the MaxQuant “intensity”
measurements and the “Match between runs” feature enabled, which quantified non-
sequenced peptide features based on accurate mass, retention time, and sequence
information collected from other data-dependent LC-MS/MS runs. Only unmodified
peptides designated as unique at the protein group level were used to calculate summed
protein intensities. The intensity ratio of Tbx20 in the eh1mut/wild type isolation was used
to normalize protein interaction ratios. The normalized fold-differences of putative
interactions (Tbx20eh1mut isolation relative to the wild-type Tbx20) were used as a measure
of differential interaction. Interacting proteins with fold-differences ≤ 0.5 were considered to
be significantly reduced in mutant isolations (Supplemental Tables 5, 6).
Construction of a HEK293 HDAC2-EGFP stable cell line
The HDAC2 ORF was amplified from an HDAC2 plasmid (gift from E. Seto, Moffitt Cancer
Center), and inserted into the pLXSN-C-EGFP-FLAG vector to create the HDAC2-EGFP-
flag fusion, as in 20. The Phoenix™ retrovirus expression system (Orbigen, San Diego, CA)
was used to transduce HEK293 cells to express the HDAC2-EGFP-FLAG fusion according
to the manufacturer's instructions. The transduced cells were selected in 300 mg/L G418
(EMD, Gibbstown, NJ) and sorted by FACS (Vantage S.E. with TurboSort II, Becton
Dickinson, Franklin Lakes, NJ) to obtain a stable cell line. The nuclear localization and
deacetylation activity of the GFP-tagged HDAC2 were confirmed.
Isolation of endogenous Tbx20 from mouse embryonic hearts
Pregnant CD1 females were sacrificed on embryonic day 10.5 (E10.5) and the embryos
removed. Embryonic hearts (n=25) were dissected from the embryos in cold PBS and snap-
frozen in liquid nitrogen. Embryonic hearts were cryogenically lysed, and endogenous
Tbx20 protein complexes were immunoaffinity purified as described using 5 mg magnetic
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beads (M270 Epoxy Dynabeads, Invitrogen) conjugated to anti-Tbx20 antibodies (Santa
Cruz Biotechnology). The isolated proteins were analyzed by Western blotting.
Immunofluorescence and immunoblotting
For immunofluorescence of HEK293 cells, cells were cultured in 8-well chamber slides
pretreated with poly-D-lysine. For live imaging of EGFP fluorescence, cells were
transfected with pMONO-Tbx20-EGFP. Forty-eight hours later, the cells were rinsed with
1X PBX and DAPI added (200 ng/mL in 1X PBS) for 30 min. Cells were imaged by
confocal microscopy on a Zeiss 710.
Antibodies used for immunoblotting include mouse anti-GFP (JL8) (Clontech Living Colors
Monoclonal), mouse anti-Flag (M2) (Sigma), goat anti-TLE1 (N-18) (Santa Cruz
Biotechnology), rabbit anti-TLE3 (M-201) (Santa Cruz Biotechnology), mouse anti-
GAPDH (Millipore), and goat anti-Tbx20 (Santa Cruz Biotechnology).
RNA extraction and RT-PCR
RNA was extracted using Trizol (Invitrogen) and purified on RNeasy columns (Qiagen).
cDNA synthesis was performed from 0.5-1 μg of RNA using random primers and
SuperScript II reverse transcriptase (Invitrogen). Expression levels were assessed using
GoTaq Green Master Mix (Promega) and Taq polymerase on a GeneAmp PCR System
(Applied Biosystems). PCR products were analyzed by 2.5% agarose gel electrophoresis.
In situ hybridization
E10.5 embryos were fixed whole in 4% paraformaldehyde and 16 μm tissue sections were
cut for in situ hybridization. Fragments corresponding to the 5’ UTR of Tbx20, TLE1, and
TLE3 transcripts were cloned into a pStrataclone cloning vector (Strataclone Blunt PCR
Cloning Kit, Agilent Technologies), then digoxigenin-labeled antisense riboprobes were
generated and hybridized to the tissue sections using standard techniques. Sections were
imaged on an Olympus BX61 Upright Wide Field microscope.
RNA-seq and differential expression analyses
RNA was extracted from stage 13 Xenopus laevis embryos injected with Tbx20-EGFP or
Tbx20eh1mut-EGFP mRNA. As a control, RNA was also extracted from uninjected stage 13
siblings. The Illumina Tru-seq RNA sample prep kit was used for cDNA library preparation.
Libraries were sequenced using an Illumina HiSeq 2500 system (Vanderbilt Technologies
for Advanced Genomics, Vanderbilt University). Each sample (two replicates per condition)
generated between 32 million and 38.5 million single-end, 50-bp reads. These were mapped
to a set of 8,879 X. laevis transcripts using the default options of Bowtie2 (version 2.1.0) 21
as described previously22, with a unique-mapping rate of 45-47%. Bowtie2 output files were
converted to binary forms and sorted using Samtools (version 0.1.19)23. Transcript
assemblies and expression level quantification were performed on each sample using the
default settings of Cufflinks (version 2.0.2)24. The transcript lists were subsequently merged
using the default settings of the Cuffmerge script in Cufflinks to produce a comprehensive
list of transcripts represented in all our Cufflinks assemblies (Supplemental Tables 7, 8).
Differential expression analysis was performed on all samples using the default settings of
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the Cuffdiff program in Cufflinks, with the bias detection and correction option (-b) and the
multi-mapping correction option (-u) (Supplemental Tables 7, 8). Gene ontology analysis
was performed using GOrilla25 (Supplemental Table 9, 10). Heat maps were generated using
the heatmap.2 function of the gplots package (R package version 2.11.3, R Foundation for
Statistical Computing, Vienna, Austria) in R (version 3.0.1, R Foundation for Statistical
Computing, Vienna, Austria).
Results
Tbx20-EGFP is localized to the nucleus and transcriptionally active
Identification of critical Tbx20 protein co-factors in a high throughput manner has been
hampered by a lack of antibodies against Tbx20 that are suitable for directed proteomics
analyses. Additionally, there are no cell lines that recapitulate endogenous Tbx20 expression
and thus could provide sufficient material for large-scale proteomics studies of Tbx20
protein complexes. Since the main goal of this set of studies was to determine the general
transcriptional mechanisms by which Tbx20 functions, we generated human embryonic
kidney (HEK293) cells expressing Tbx20 tagged at the C-terminus with EGFP (Figure 1A).
HEK293 cells have been used as a cell culture model for studies on the transcriptional
activity of Tbx20 4a, b, indicating that this cell line contains the necessary cohort of
transcriptional co-factors required for Tbx20-mediated transcriptional regulation. In
agreement with its known role in transcription, Tbx20-EGFP localizes to the nucleus when
expressed in HEK293 cells, as shown by live GFP fluorescence microscopy (Figure 1B).
To confirm that the EGFP-tagged Tbx20 is transcriptionally active, we made use of a
Xenopus animal cap assay. The animal cap is a region of the Xenopus blastula and early
gastrula stage embryo (stages 8/9) that consists of naïve pluripotent cells. Animal caps
normally contribute to skin and nervous tissue; however, a recent study demonstrated that
animal caps excised from embryos injected with Tbx20 mRNA express the early mesoderm
marker Xbra, but not the skeletal muscle marker Myf5, indicating that Tbx20 can induce cell
fate changes in the early embryo 5a. To assess whether EGFP-tagged Tbx20 has the same
ability to induce gene expression changes as untagged Tbx20, we injected Tbx20 and Tbx20-
EGFP mRNA into one-cell stage Xenopus laevis embryos. By stage 9, Tbx20-EGFP protein
is localized throughout the animal pole of the embryo, as shown by live GFP fluorescence
microscopy (Figure 1C). At this stage, animal caps were excised from Tbx20- and Tbx20-
EGFP-injected embryos and cultured in isolation until uninjected sibling whole embryos
reached stage 13. After extraction of RNA, we assessed the expression of the early
mesodermal markers chordin and Xbra, and as a negative control, Myf5, by RT-PCR. The
levels of induction were compared to expression of these genes within whole embryos,
untreated caps, and, as a positive control, caps treated with the mesoderm-inducing factor
Activin. Both EGFP-tagged Tbx20 and untagged Tbx20 induce chordin expression to the
same degree as Activin (Figure 1D). Further, Tbx20 and Tbx20-EGFP induce moderate
levels of Xbra compared to Activin-induced caps; however, there was no induction of the
muscle marker Myf5 by either version of Tbx20 or by Activin treatment. Untreated caps did
not express any of the tissue-specific markers tested. These data indicate that EGFP-tagged
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Tbx20 is transcriptionally active and retains the ability to modulate downstream gene
expression.
Proteomic analysis of Tbx20-EGFP interactions reveals association with a unique
chromatin remodeling network
To systematically identify Tbx20-associated proteins, we performed immunoaffinity
purifications of Tbx20-EGFP complexes from HEK293 cells using a high affinity in-house
developed antibody against GFP 12. In parallel, as controls, we performed immunoaffinity
purifications from cells expressing EGFP alone (Supplemental Tables 1, 2). Immunopurified
proteins were partially resolved by SDS-PAGE, digested in-gel with trypsin, and analyzed
by nLC-tandem MS (MS/MS) on an LTQ Orbitrap XL or an LTQ Orbitrap Velos. Three
independent biological replicates were performed (Supplemental Tables 1,2); two of these
immunopurifications were performed in the presence of DNase to eliminate interactions
mediated by binding of factors on adjacent DNA sequences. Raw MS/MS spectra from each
experiment were analyzed by SEQUEST database searches (Proteome Discoverer) and
loaded into Scaffold for further analysis. Protein identifications from all three replicates
were filtered using stringent confidence parameters (see Materials and Methods). A
spectrum counting approach was employed to assess enrichment of protein interactions with
Tbx20-EGFP relative to EGFP alone. First, proteins were required to be reproducibly
present, detected by at least 5 spectrum counts. Second, proteins showing less than 2.5-fold
spectrum count enrichment over proteins co-isolated with EGFP alone were deemed non-
specific and were excluded. Further, given the nuclear localization of Tbx20-EGFP, proteins
lacking a nuclear gene ontology term were excluded as likely non-specific associations
occurring during whole-cell lysis (Supplemental Table 2).
In total, 114 proteins with annotated nuclear localization passed our spectrum count and fold
enrichment criteria, 97% of which occur in all three biological replicates. There were no
proteins identified as unique to a single Tbx20-EGFP isolation; however, 3 proteins, while
detected in all three isolations, failed to pass our stringent criteria in one of the three
experiments (Supplemental Table 1). To assess the Tbx20 nuclear interaction network, we
classified the proteins passing our spectrum count and fold enrichment criteria into
functional subgroups by Cytoscape, using the ClueGO plugin 14-15. Specifically, proteins
were assigned into gene ontology (GO) term clusters according to biological function
ontologies. When we examined Tbx20 nuclear interactions, the most prominent biological
function category contained 53 proteins related to RNA processing (Figure 2A and
Supplemental Table 3). This is expected, as it is well established that the DNA template that
is being actively transcribed is often closely associated with the RNA processing machinery
and suggests that a portion of Tbx20 binding is closely associated with active transcription.
Nuclear interactions also included 13 proteins involved in nucleosome assembly (Figure 2A
and Supplemental Table 3). Nucleosome assembly functions were represented by such GO
terms as chromatin remodeling, DNA conformation change, and nucleosome organization ,
indicating a crucial role for Tbx20 in modification of chromatin architecture. Sixteen
proteins were assigned to DNA repair/synthesis, and 10 proteins were assigned to nuclear
transport (Figure 2A and Supplemental Table 3). Collectively, these putative Tbx20
interactions represent different complexes and functions of Tbx20 throughout the nucleus.
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Given the lack of knowledge regarding the molecular mechanisms of Tbx20-mediated
transcriptional regulation, we reasoned that the specific protein functions represented within
the ‘nucleosome assembly’ category could provide new insight on the potential roles of
Tbx20 in gene regulation. Moreover, since chromatin remodeling and transcription
repression complexes are often large multi-protein complexes, we speculated that the
specific proteins represented within the ‘nucleosome assembly’ category were likely to be
interconnected. To test this hypothesis, we analyzed the proteins within this functional
cluster (Table 1 and Supplemental Table 3) using STRING, a knowledge database of known
and predicted protein-protein interactions16, with the aim of generating a predictive Tbx20
interaction network. Eight of these proteins form a highly interconnected network containing
chromatin remodeling and deacetylase functions and include the nucleolar proteins
Nucleophosmin (NPM1) and Nucleolin (NCL), as well as core components of the
Nucleosome Remodeling and Deacetylase (NuRD) complex (MTA1, RBBP4, RBBP7, and
HDAC2)—a major ATP-dependent chromatin remodeling complex with important roles in
transcription and chromatin assembly (reviewed in 26) (Table 1 and Figure 2B, gray lines).
NCL and MTA1 were integrated into this network based upon their known or predicted
functional association with components of the chromatin remodeling network 27.
Additionally, this network includes two members of the INO80 chromatin remodeling
complex, the ATPases RUVBL1 and RUVBL2. The INO80 complex is a highly conserved,
multisubunit, ATP-dependent chromatin remodeling complex that contributes to both
transcriptional activation and repression 28.
As this is the first demonstration that Tbx20 associates with chromatin remodeling proteins,
it was unclear how Tbx20 might be functionally linked to this chromatin modification
network. There is evidence that MTA family proteins interact directly with transcription
factors at target gene loci 29; however, different transcription factors have been shown to
bind to different regions of individual subunits of the NuRD complex 30. To attempt to
identify the functional link between Tbx20 and the chromatin remodeling network, we first
examined the list of nuclear-enriched proteins for additional components of a chromatin
modification network that may have been excluded in our original analysis due to
incomplete GO or functional annotation. Surprisingly, this search uncovered the
transcriptional co-repressors Transducin-like Enhancer of split 1 and 3 (TLE1 and TLE3)
and the T-box transcriptional repressor Tbx18. TLE family members are orthologs of the
Drosophila Groucho protein and have been previously demonstrated to bind directly to T-
box factors, including Tbx18 and Tbx15, through an engrailed homology 1 (eh1) binding
motif and achieve transcriptional repression by recruiting histone deacetylases 31. Based
upon the reported functional relationships between TLE proteins, T-box factors, and
HDACs, we incorporated TLE1/3 and Tbx18 into the STRING network (Table 1 and Figure
2B, black lines).
To examine if Gro/TLE factors could serve as proximal interacting partners, linking Tbx20
to chromatin remodeling complexes, we estimated the relative enrichment of proteins within
the interaction network. As previously described 6, 13, the relative protein enrichment within
the immunoisolates was estimated by normalizing their relative protein abundances (NSAF
values) 17 to their proteome abundances from the PAX database (pax-db.org) (Supplemental
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Table 4). This relative enrichment analysis was performed for the 114 proteins enriched in
Tbx20 immunoisolations and in the “nuclear” GO subcellular localization (Supplementary
Table 3). Respective enrichment index values were then illustrated in the Gro/TLE-
chromatin remodeling network (Figure 2B). We hypothesized that proteins within the
interaction network having greater enrichment indices would represent more proximal and
perhaps essential Tbx20 interactions. Indeed, TLE1 and TLE3 comprised two of the most
highly enriched components of the interaction network. This supports a critical role for these
proteins in regulating Tbx20 function, suggesting they may be directly linked to Tbx20
(Figure 2B, black dashed lines).
Tbx20 forms protein complexes with TLE1/3, Tbx18, and HDAC2
While our AP-MS analysis of Tbx20 complexes does not establish which proteins are direct
interactions (Figure 2B, black dashed lines), other T-box proteins, Tbx15 and Tbx18, have
been reported to bind directly to TLE3 via N-terminal eh1 binding motifs 32, indicating that
the eh1 motif may represent a common motif used by T-box transcription factors to bind
Gro/TLE family members. Therefore, to determine whether Tbx20 directly recruits Groucho
co-repressors via an eh1 binding motif, we next investigated the interaction between Tbx20
and TLE1/3. Tbx20 contains an N-terminal eh1 binding motif that is fully conserved in all
vertebrate orthologs of Tbx20 (Figure 3A). To confirm an interaction between Tbx20 and
TLE1/3 and determine whether these interactions require the eh1 motif, we generated a
Tbx20eh1mut-EGFP expression construct in which the eh1 motif has been ablated by site-
directed mutation of phenylalanine 18 and serine 19 to an isoleucine and a leucine,
respectively (Tbx20F18I; S19L-EGFP). Reciprocal immunoisolations of TLE1 and TLE3
complexes were performed in the presence of wildtype Tbx20-EGFP or Tbx20eh1mut-EGFP.
Mutation of the eh1 motif significantly reduced the ability of Tbx20-EGFP to be co-isolated
with either TLE1 or TLE3, suggesting that Tbx20 binds TLE1/3 directly through this motif
(Figure 3B,C).
The finding that Tbx20 interacts with both a Gro/TLE complex and the Groucho dependent
repressor Tbx18 32 suggests that Tbx20 and Tbx18 may heterodimerize to regulate a
common set of targets in a Groucho-dependent manner. To further investigate the interaction
between Tbx20 and Tbx18, we transfected HEK293 cells with Tbx18-Flag alone or in the
presence of Tbx20-EGFP. Immunopurification with an anti-Flag antibody and Western blot
analysis revealed efficient co-isolation of Tbx20 (Figure 3D). Collectively, these data imply
a role for a Tbx20-Tbx18 repressor complex during vertebrate development.
To investigate the link between the Tbx20-TLE1/3 complex and HDAC2, we generated an
HEK293 cell line stably expressing HDAC2 tagged at the C-terminus with EGFP. To
confirm an interaction between Tbx20 and HDAC2, we performed reciprocal isolations of
HDAC2-EGFP in the presence or absence of Tbx20-HA. Tbx20 was successfully co-
isolated with HDAC2-EGFP (Figure 3E). As a number of studies indicate that binding to
Groucho co-factors results in recruitment of deacetylase machinery 31, 33, we also performed
isolations of HDAC2-EGFP in the presence of over-expressed TLE3 and Tbx20.
Interestingly, excess TLE3 results in a substantial increase in the amount of Tbx20
associated with HDAC2, suggesting that TLE3 bridges an interaction between Tbx20 and
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HDAC2 (Figure 3E). However, less TLE3 associates with HDAC2 when Tbx20 is
overexpressed; therefore, an alternate explanation is that Tbx20 competes with TLE3 for
binding to HDAC2.
Label-free mass spectrometry analysis reveals that Tbx20:TLE binding triggers
recruitment of NuRD components
To distinguish between these possibilities and to assess precisely which components of the
chromatin modification network (Figure 2B) are dependent on the Tbx20-TLE3 interaction,
we used label-free mass spectrometry to assess the differences between Tbx20-EGFP and
Tbx20eh1mut-EGFP protein complexes. To do this, we expressed Tbx20-EGFP and
Tbx20eh1mut-EGFP in HEK293 cells and performed parallel isolations of EGFP-tagged
Tbx20 complexes, as described above. Changes in the relative abundance of interacting
chromatin remodeling factors between wild-type and mutant Tbx20 complexes were
assessed using two label-free quantification approaches: 1) spectral counting, and 2) MS1
peak area quantification (see Materials and Methods). To correct for the total amount of
isolated Tbx20 complexes between conditions, we normalized the quantitative values for
associated proteins identified in mutant Tbx20 complexes by the ratio of wild-type/eh1mut
Tbx20-EGFP. Also, Tbx18 was excluded from label-free quantification due to the presence
of only one tryptic peptide that was exclusive to Tbx18 (the other peptide was isobaric with
a tryptic peptide from Tbx20).
Consistent with our previous Western blot analysis (Figure 3B-C), we no longer identified
TLE1 or TLE3 in the Tbx20eh1mut mutant isolation (Figure 4A and Supplementary Table 5).
We also observed an eh1mut-dependent spectral count fold-decrease that was specific to
components of the NuRD complex, though with variation in the magnitude of the decrease
between proteins (Figure 4A). To address this variation, we also employed MS1-based
quantification, which allows more precise measurement of relative abundance, particularly
for proteins with few spectral counts (e.g. in the mutant isolation, Supplemental Table 5)
and/or with shared tryptic sequences (e.g., RBBP4 and RBBP7). MS1-based analysis
confirmed the spectral counting result for TLE1/3, suggesting a relative decrease of at least
10-fold in the eh1mut vs wild-type Tbx20 (Supplemental Table 6). Further, we observed that
association with HDAC2, MTA1, and the histone binding proteins RBBP4/RBBP7 was
significantly reduced and to a similar extent in the eh1mut compared to wild-type Tbx20,
indicating that the interaction of Tbx20 with NuRD complex components is partially
Groucho-dependent (Figure 4A,B and Supplemental Table 5, 6). These data suggest that
TLE co-repressors play a central role in the formation of a Tbx20 transcriptional repressive
complex by recruiting core components of the NuRD complex including HDAC2. Overall,
these results demonstrate that this AP-MS approach can efficiently isolate and identify
specific Tbx20 interactions, which may help to define the mechanisms involved in Tbx20-
mediated gene regulation.
Endogenous Tbx20 interacts with TLE factors in mouse embryonic hearts
Our proteomic analysis suggests that Tbx20 is linked to a transcriptional repressive complex
via direct interaction with a TLE family member. To assess the endogenous Tbx20
association with TLE family members in vivo at the time in embryogenesis at which Tbx20
Kaltenbrun et al. Page 12






















has been shown to function, we first examined the expression of all of the TLE family
members in mouse embryonic day 10.5 (E10.5) heart tissue by RT-PCR. At this stage of
development, Tbx20 is uniformly expressed throughout the four-chambered embryonic
heart 34 where it is required for proper transcriptional regulation of cardiac chamber-specific
genes4b-e. All of the TLE family members are highly expressed at this time, with the
exception of TLE2, which is expressed at relatively low levels (Figure 5A). To further
confirm that Tbx20 co-localizes with TLE1/3 within the same cells of the embryonic heart,
we performed in situ hybridization for Tbx20, TLE1, and TLE3 transcripts on serial tissue
sections from an E10.5 heart. This analysis revealed that TLE1 and TLE3 are expressed
broadly with Tbx20 throughout the myocardium (Figure 5B-G).
Importantly, we were able to detect an interaction between endogenous Tbx20 and both
TLE1 and TLE3 in the embryonic heart, indicating that Tbx20 binds both TLE factors in
vivo during heart development (Figure 5H). This finding represents the first demonstration
of endogenous Tbx20 protein-protein interactions from an embryonic heart. These data
further validate our proteomic approach and demonstrate that Tbx20 assembles a TLE
repressor complex in the embryonic heart at the time at which Tbx20 functions in cardiac
development.
Ablation of Tbx20:TLE binding disrupts Tbx20-mediated transcriptional repression in
Xenopus embryos
Having established that Tbx20 assembles a TLE co-repressor complex in the forming heart,
we next sought to establish the consequences of Tbx20:TLE binding on Tbx20 biological
activity. To address this issue, we examined whether Tbx20eh1mut mutant protein could
promote morphogenetic changes in the embryo when ectopically expressed in developing
Xenopus laevis embryos. Xenopus embryos were injected at the one-cell stage with Tbx20-
EGFP or Tbx20eh1mut-EGFP mRNA and allowed to develop until control uninjected
embryos reached tailbud stages (stage 23/33). Ectopic expression of Tbx20-EGFP
drastically disturbs cell movements during gastrulation, leading to a marked shortening of
the anterior/posterior axis, consistent with a previous report 5a (Figure 6A, B). Strikingly,
these defects are partially rescued by ablation of the eh1 binding motif, indicating that
recruitment of TLE factors is critical for the ability of Tbx20 to promote changes in
morphogenesis (Figure 6C). This finding is supported by the observation that Tbx20-EGFP
and Tbx20eh1mut-EGFP are expressed at comparable levels from injected mRNAs, as shown
by Western blotting for GFP (Figure 6D).
Our findings are consistent with an essential role for Tbx20-TLE repressor complexes in
embryonic heart formation. To gain insights into what molecular processes and genes are
regulated by Tbx20-TLE complexes, we used high-throughput sequence analysis to examine
the transcriptomes in Tbx20-EGFP and Tbx20eh1mut-EGFP-injected embryos. Specifically,
we sought to identify genes downregulated by Tbx20-TLE repressor complexes. We chose
stage 12.5 (early neurula-stage) embryos for analysis because misexpressed Tbx20 leads to
gene expression changes at this stage (Figure 1D), and to eliminate the detection of gene
expression changes induced by endogenous Tbx20 transcripts, which can be detected as
early as stage 16 3e. A total of 201 genes were significantly downregulated at least 2-fold by
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ectopic Tbx20 when compared to control uninjected embryos (Supplemental Figure 1). Of
these 201 genes, 173 were not repressed by ectopic expression of Tbx20eh1mut protein (86%
of genes downregulated by wild-type Tbx20; Supplemental Figure 1 and Supplemental
Table 9), indicating a role for Tbx20-TLE complexes in negative regulation of this group of
genes. Gene ontology enrichment analysis revealed a trend whereby the 173 genes not
repressed by Tbx20eh1mut were significantly enriched for functions involving anterior/
posterior pattern specification, regulation of cell differentiation and transcription, regulation
of the Wnt signaling pathway, and tissue patterning (Figure 6E and Supplemental Table 10),
cellular processes known to be associated with Gro/TLE repressive function in the
embryo 35. Indeed, upon ranking the 173 genes uniquely repressed by Tbx20
overexpression, the 40 genes most differentially regulated between Tbx20- and
Tbx20eh1mut-expressing embryos included hox genes involved in anterior/posterior
patterning (hoxa7, hoxc10, hoxd4, hoxc9, hoxa2)36, transcription factors important for
control of cellular differentiation (irx3, tbx3, gata3, and nkx6.2), and a number of Wnt
signaling pathway components (frzb, dkk1, frzb2) (Figure 6F). Notably, Irx3 has recently
been identified as a direct ChIP-seq genomic target of Tbx20 in the adult heart, and a recent
study finds that Tbx20 directly regulates Wnt pathway genes in the endocardial cushions,
suggesting that our RNA-seq analysis identified primary mediators of Tbx20 cardiac
function 5b, 37. Additionally, early, ectopic expression of Tbx20 leads to downregulation of a
number of genes with important roles in cardiac muscle tissue morphogenesis, including the
cardiac transcription factors nkx2.5, isl1, pitx2, and foxc1 (Figure 6E, F and Supplemental
Table 10). Interestingly, these cardiac genes are not downregulated by Tbx20eh1mut protein
(Figure 6E, F and Supplemental Table 10), implying that in the absence of other cues (ie.
transcriptional coactivators), Tbx20 may act in combination with TLE repressor complexes
to repress cardiac promoters. Collectively, these results provide additional evidence that
Tbx20-mediated repression is facilitated by Gro/TLE complexes.
Conclusions
Despite the critical role of Tbx20 in cardiac development, the precise mechanisms by which
Tbx20 regulates distinct gene programs in the heart are not understood. Studies in mouse
knockout models of Tbx20 indicate that Tbx20 is required for proper patterning and
morphogenesis of working myocardium 4b-e. Thus, activating and/or repressive activity of
Tbx20 on target genes underlies the primary cardiomyocyte lineage split into specialized
chamber and non-chamber myocardium. To identify and characterize the determinants of
Tbx20 transcriptional activity in the heart, it is essential to identify Tbx20 interacting
proteins. Our study constitutes the first unbiased analysis of Tbx20 protein interactions.
Using a proteomics/bioinformatics approach, we identified a unique transcriptional
repression network that includes Groucho co-repressors, components of the NuRD complex,
components of the INO80 chromatin remodeling complex (RUVBL1 and RUVBL2), and
the T-box repressor Tbx18.
A Tbx20-TLE-NuRD repressor complex
The Tbx20 homolog Midline was recently demonstrated to bind Groucho directly in an eh1-
dependent manner in Drosophila whole embryos, and this interaction was required for
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proper transcriptional repression of the wingless gene during segmentation of the
ectoderm 38. Our studies confirm and expand upon this work by demonstrating that 1)
vertebrate Tbx20 interacts with Groucho homologs, 2) vertebrate Tbx20 interacts with at
least two members of the Groucho-related TLE family, TLE1 and TLE3, in human cells and
in the mouse embryonic heart through the eh1 motif, and 3) Tbx20-TLE interactions directly
result in the recruitment of components of the chromatin-remodeling NuRD complex
including HDAC2. These data suggest that recruitment of Gro/TLE co-repressor complexes
and subsequent deacetylation of target loci represent an evolutionarily conserved mechanism
by which Tbx20 functions and thus, one mode by which Tbx20 promotes inactive chromatin
states during development. A thorough expression analysis of TLE factors in the developing
heart has not been published; although, it has been reported that TLE1 and TLE3 transcripts
were not detectable in the mouse embryonic heart by in situ hybridization 39. Our data,
however, suggests that most members of the mouse TLE family are expressed in the heart at
stage E10.5 of embryogenesis. Further, we find that TLE1 and TLE3 transcripts are broadly
expressed throughout the E10.5 myocardium by in situ hybridization. Finally, TLE1 and
TLE3 proteins co-isolate with endogenous Tbx20 at E10.5. The availability of other TLE
factors in the heart, and our results showing that Tbx20 interacts with both TLE1 and TLE3,
suggests that Tbx20 may interact with multiple members of this family to cooperatively
regulate genes in the heart. As such, it will be interesting to determine whether other TLE
family members have distinct temporal and spatial expression patterns in the forming heart
or whether they can act redundantly on Tbx20 target genes.
Our proteomic and biochemical analyses of Tbx20 complexes indicate that binding of TLE
factors by Tbx20 results in the recruitment of core components of the NuRD complex40,
specifically, the histone binding proteins RBBP4 and RBBP7, MTA1, and HDAC2.
Historically, requirements for the NuRD complex in early cell fate decisions in the embryo41
have prevented the identification of a role for NuRD specifically in the heart; however,
HDAC2 is ubiquitously expressed in developing myocardium 42, and mice that are mutant
for both HDAC1 and -2 die neonatally of cardiac arrhythmias and dilated cardiomyopathy43.
Taken together, these studies implicate an important role for a Tbx20-NuRD association in
developing cardiomyocytes.
Interestingly, interactions with the remainder of the chromatin remodeling network were
unaffected by the eh1 mutation, suggesting that they are recruited independently of the eh1
binding motif and TLE recruitment. Of note, RUVBL2 (also called Reptin) was
demonstrated to co-occupy the Hesx1 promoter with TLEs and HDAC1 to silence Hesx1
expression during mouse pituitary development 44, indicating that this protein, although still
present within Tbx20eh1mut mutant complexes, may be part of an intact TLE corepressor
complex via recruitment by a as yet unidentified binding motif within Tbx20.
The finding that Tbx20 represses cardiac genes when ectopically expressed in early Xenopus
embryos indicates that Tbx20 activating or repressive activity is likely context dependent.
Previous studies have reported that Tbx20, in combination with other cardiac transcription
factors, primarily acts to promote cardiac gene expression while repressing genetic programs
of other tissues 4e, 5a, 5c. In accordance with this, we identified genes essential for
vasculogenesis, eye development, neural crest development, and motor neuron development
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downregulated by Tbx20 misexpression. Given that Tbx20 misexpression also
downregulates cardiac transcription factors, one possibility is that additional tissue-specific
factors or cues are needed to antagonize default repression achieved by Tbx20. Indeed, we
observed that Tbx20eh1mut mutant protein fails to repress these genetic programs, implying
that displacement of the TLE corepressor complex is sufficient to abolish Tbx20 repressive
activity on these genes. As such, it would be interesting to determine whether TLE-mediated
repression can be out-competed by cardiac coactivators in the context of a cardiac progenitor
or myocyte. This principle has been illustrated previously by the role Gro/TLE plays in cells
that do not receive Wg/Wnt signaling. Binding of Gro/TLE to Tcf/Lef repressors on
Wg/Wnt target genes blocks recruitment of beta-catenin, an obligatory Tcf/Lef coactivator.
Effective Wg/Wnt signaling leads to accumulation of beta-catenin, which subsequently can
out-compete Gro/TLE for binding to Tcf/Lef 45. Thus, the level of Wn/Wnt signaling via
beta-catenin accumulation dictates which cofactor binds Tcf/Lef, leading to transcription
activation or repression. Our data therefore highlight a unique mechanism by which TLE-
mediated repression may function as a context-dependent regulatory switch required for
Tbx20 to alternate between activator and repressor.
A Tbx20-INO80 complex
The INO80 chromatin remodeling complex is a very large protein complex with 11 to 16
members including the ATP-dependent helicases Ino80 and SRCAP, the DNA helicases
Pontin (Ruvbl1, Tip49, Tip49a) and Reptin (Ruvbl2, Tip48, Tip49b), actin, and various
actin-related proteins (Arp4, Arp5, Arp8, β-actin, Arp7, Arp9) 28. The INO80 complex alters
chromatin accessibility resulting in activation or repression of target genes 46. Two members
of the complex, Pontin and Reptin, have opposing acitivities within the INO80 complex, and
this antagonistic relationship has been shown to play a role in cardiac growth in zebrafish 47.
An ENU-induced mutation in Reptin leads to cardiac hyperplasia and embryonic lethality.
This mutation is an activating mutation in Reptin, increasing the ATPase activity of Reptin
complexes, thus overriding Pontin inhibition of Reptin activity, and increasing the
transcriptional repressor activity of the complex. Mutant zReptin was subsequently shown to
have a stronger repressive effect on beta-catenin/TCF-mediated transactivation, leading to
the hypothesis that Pontin/Reptin complexes regulate beta-catenin-mediated activation of
cell cycle genes such as cyclin D and c-Myc to control the balance between proliferation and
differentiation in the developing zebrafish heart 47. Our data suggests that Tbx20 interacts
with a RUVBL1-RUVBL2 protein complex independently of its association with a TLE
repressor complex, suggesting that Tbx20 may also recruit the INO80 complex for gene
regulation. Tbx20 has a well-documented role in cardiomyocyte proliferation4b and seems to
exert opposite effects on cell proliferation in embryonic versus fetal cardiomyocytes48.
Therefore, it is tempting to speculate that association of Tbx20 with the INO80 complex in
fetal cardiomyocytes underlies this switch in the activity of Tbx20 transcriptional
complexes.
A Tbx20-Tbx18 complex
An unexpected finding of these studies is that Tbx20 interacts with the tissue-specific
transcription factor Tbx18. In the developing heart, Tbx18 expression overlaps with that of
Tbx20 in a subset of cardiomyocytes within the interventricular septum and a portion of the
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left ventricle at a stage when the heart is undergoing chamber specialization and expansion,
processes that are both dependent on proper Tbx20 function 3f, g, 49. Thus, interaction with
Tbx18 in this subset of cardiomyocytes provides one potential mechanism through which
Tbx20 may function to regulate regionally distinct gene programs in the heart. Tbx18 is also
expressed in the epicardium, an epithelial monolayer that covers the myocardium and is a
critical source of signals and cells for the underlying myocardium 34. Recently, a microarray
analysis of isolated epicardial cells revealed Tbx20 as an epicardium-enriched transcription
factor 50, opening the possibility for a Tbx18-Tbx20 transcriptional complex within the
epicardium. Tbx18 also plays a prominent role in formation of the myocardial sinus horns
that make up the venous pole of the heart; however, it is not clear whether Tbx20 is co-
expressed with Tbx18 within this tissue 51. Additionally, our lab has previously reported that
Tbx20 interacts physically with Tbx5 4a, suggesting that heterodimerization with other T-
box factors may represent an important mechanism by which Tbx20 regulates gene
expression in the embryo.
Interestingly, Tbx18 has also been shown to interact with TLE3 via an eh1 binding motif
within the N-terminus of the protein 32. In this study, transcriptional assays demonstrated
that Tbx18 can repress activation of the Nppa/ANF promoter by the cardiac transcription
factors Gata4, Nkx2.5, and Tbx5. This finding was interpreted as Tbx18 abrogation of
Nppa/ANF expression through competition with Tbx5, a second T-box protein, for T-box
binding sites (TBEs) within the Nppa/ANF promoter. Similarly, Tbx18 is predicted to
repress Tbx6-mediated activation of the Notch ligand Delta-like 1 (Dll1) in anterior somites
through competition with Tbx6 32. Collectively, these data imply a model in which Tbx18
competes with other T-box activators for occupancy of TBEs and subsequently achieves
repression by recruiting a TLE co-repressor complex to the target gene. Here, we have
demonstrated the Tbx20 and Tbx18 physically interact, and Tbx20 recruits a TLE repressor
complex similar to that reported for Tbx18. Therefore, a second model predicts that Tbx18
and Tbx20 may be acting cooperatively as repressors on a common set of target genes.
Further studies are needed to distinguish between these possibilities.
In summary, the goal of our study was to expand upon the current knowledge of the Tbx20
transcriptional network. By combining immunoaffinity purification with proteomic and
functional network analysis, we have identified a Tbx20 transcription repression network
with chromatin remodeling and deacetylase functions. In particular, our results reveal a
crucial role for Gro/TLE-NuRD corepressor complexes in facilitating Tbx20-mediated
transcriptional repression. We also identified Tbx18 as a Tbx20 interaction, raising the
question of whether Tbx20 transcriptional repression relies on cooperative activity of Tbx20
and other cardiac transcription factors, similar to what has been shown for Tbx20
transcriptional activation in the presence of the activators Gata4, Nkx2.5, and Tbx5 4e, 5a.
Future studies will aim to delineate the biological role of these repressive interactions,
particularly as they relate to regulation of the cardiogenic program.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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ABBREVIATIONS
NuRD Nucleosome Remodeling and Deacetylase
TLE Transducin-like Enhancer of Split
Gro Groucho
HEK293 Human Embryonic Kidney 293
HDAC2 Histone Deacetylase 2
AP-MS Affinity Purification-Mass Spectrometry
MTA1 Metastasis-associated protein 1
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Tbx20-EGFP is nuclear-localized and transcriptionally active. (A) Schematic of EGFP-
tagged (green) Tbx20 expression construct, showing the N-terminal (white), T-box (black),
transactivation (blue), and repression (brown) domains. A putative Tbx5 protein-protein
interaction (PPI) domain lies within the N-terminus and T-box. Numbers denote amino acid
residues. (B) Tbx20-EGFP is localized to the nucleus in HEK293 cells, as confirmed by live
GFP fluorescence and colocalization with DAPI. (C) Tbx20-EGFP mRNA was injected at
the 1-cell stage into Xenopus embryos. Expression of Tbx20-EGFP in the animal pole of
stage 9 Xenopus embryos was confirmed by live GFP fluorescence. (D) RT-PCR analysis of
the mesodermal genes chordin and Xbra and the skeletal muscle gene Myf5 in stage 13
whole embryos, stage-matched untreated animal caps, Activin-treated animal caps, Tbx20-
injected animal caps, and Tbx20-EGFP-injected animal caps. The housekeeping gene Gapdh
was used as a loading control for all RT-PCR reactions.
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Shotgun proteomics of Tbx20-EGFP protein complexes reveals association with a chromatin
remodeling and Groucho transcriptional protein network. (A) GO enrichment analysis of
Tbx20 interactions using ClueGO clustering according to biological function ontologies. (B)
The Cytoscape network was assembled from automated retrieval and manual curation of
protein functional associations using STRING analysis (grey lines) and literature curation
(solid black lines), respectively. Potential interactions/functional associations with Tbx20
are indicated by black dashed lines. Nodes are labeled with respective gene symbols and
enrichment index values (see Materials and Methods) are represented by node size and blue
color intensity. Functional protein groupings are indicated in closed circles.
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Tbx20 interacts with TLE1/3, HDAC2, and Tbx18. (A) Protein sequence alignment of an N-
terminal eh1 binding motif in Tbx20 demonstrating complete conservation of the eh1 motif
across all vertebrate homologs of Tbx20. h, human; m, mouse; x, Xenopus; z, zebrafish. (B)
Reciprocal immunoisolations of TLE1-Flag complexes from HEK293 cells expressing either
Tbx20-EGFP or Tbx20eh1mut -EGFP. (C) Reciprocal immunoisolations of TLE3
complexes from HEK293 cells expressing either Tbx20-EGFP or Tbx20eh1mut-EGFP. (D)
Reciprocal immunoisolations of Tbx18-Flag complexes from HEK293 cells expressing
Tbx18-Flag in the presence or absence of Tbx20-EGFP. (E) Reciprocal immunoisolations of
HDAC2-GFP from HEK293 cells expressing Tbx20-HA and/or TLE3. IP,
immunoprecipitation; WB, western blot.
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Tbx20 assembles a Gro/TLE-NuRD repression complex via the eh1 binding motif. Wild-
type Tbx20-EGFP and Tbx20eh1mut-EGFP were immunoaffinity purified from HEK293
cells with associated proteins and analyzed by mass spectrometry. Fold changes for each
interaction illustrated in (A) is shown for the isolated Tbx20eh1mut mutant versus wild-type
Tbx20. (B) The relative size of the circles indicates increased or decreased relative
abundance of each interaction as determined by the MS1-based fold-change for mutant
versus wild-type Tbx20 isolations.
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Endogenous Tbx20 interacts with TLE1/3 in mouse embryonic hearts. (A) RT-PCR analysis
of TLE family members and cardiac-specific markers Nkx2.5 and Tbx20 in E10.5 heart
tissue. All samples derived from embryonic hearts dissected at E10.5. (B,C) Section in situ
hybridization analysis for Tbx20 expression on a cryosection of an E10.5 heart. Neighboring
sections from the same embryonic heart were used to assess TLE1 (D,E) and TLE3 (F,G)
expression. (H) 25 hearts were dissected, and endogenous Tbx20 complexes were isolated
with an antibody against Tbx20, analyzed by SDS-PAGE, and immunoblotted with
antibodies against TLE1 and TLE3. In parallel and as a control, a mock
immunoprecipitation was performed in the absence of Tbx20 antibody. ra, right atrium; la,
left atrium; rv, right ventricle; lv, left ventricle.
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RNA-sequencing reveals disrupted transcriptional output in Tbx20eh1mut-expressing
embryos. Xenopus embryos were injected at the one-cell stage with Tbx20 (B) or
Tbx20eh1mut (C) mRNA and allowed to develop until sibling uninjected embryos (A)
reached tadpole stages. (D) Total protein equivalent to one uninjected, Tbx20-EGFP, or
Tbx20eh1mut embryo (stage 12.5) was analyzed by SDS-PAGE and immunoblotted with an
antibody against GFP. Western blot shows comparable protein levels from injected mRNAs.
(E) Gene ontology grouping (GOrilla) of the 173 genes downregulated at least 2-fold by
wild-type Tbx20, but not by Tbx20eh1mut. GO terms enriched in this gene set were plotted
by the log of their FDR-adjusted p-values. (F) Heat map depicting differential regulation of
genes by wild-type Tbx20 and Tbx20eh1mut. The 173 genes downregulated at least 2-fold
only by wild-type Tbx20 were ranked by the fold change ratio between the mutant and wild-
type. The 40 genes with the greatest disparity between the mutant and wild-type are shown.
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Table 1
Tbx20-associated proteins identified by LC-MS/MS. Numbers represent an average across three experimental
replicates.
Protein description Gene name
GFP Tbx20-EGFP
Spectrum counts Spectrum counts Unique peptides Percent coverage
T-Box transcription factor Tbx20 Tbx20 1 707 54 73
Green fluorescent protein GFP 429 411 23 63
T-box transcription factor Tbx18 Tbx18 1 11 2 5
Transducin-like enhancer of split 1 TLE1 1 17 5 15
Transducin-like enhancer of split 3 TLE3 2 29 13 23
Histone-binding protein Rbbp4 RBBP4 3 15 7 21
Histone-binding protein Rbbp7 RBBP7 1 10 2 16
Histone deacetylase 2 HDAC2 3 11 3 14
Metastasis-associated protein MTA1 MTA1 1 7 4 7
Nucleophosmin NPM1 7 40 10 51
Nucleolin NCL 14 65 14 22
RuvB-like 1 RUVBL1 3 23 8 23
RuvB-like 2 RUVBL2 4 24 10 24
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